Millennium Management

Millennium Management Portfolio holdings

AUM $112B
1-Year Return 13.71%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Quarter Return
+3.49%
1 Year Return
+13.71%
3 Year Return
+41.74%
5 Year Return
+76.27%
10 Year Return
+245.84%
AUM
$78.1B
AUM Growth
+$6.71B
Cap. Flow
+$2.15B
Cap. Flow %
2.75%
Top 10 Hldgs %
8.97%
Holding
5,931
New
1,185
Increased
1,836
Reduced
1,830
Closed
663

Sector Composition

1 Technology 16.42%
2 Healthcare 14.95%
3 Financials 12.02%
4 Consumer Discretionary 11.76%
5 Industrials 10.14%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MD icon
3076
Pediatrix Medical
MD
$1.4B
$2.07M ﹤0.01%
+68,628
New +$2.07M
AKYA
3077
DELISTED
Akoya BioSciences
AKYA
$2.07M ﹤0.01%
+106,872
New +$2.07M
ASMB icon
3078
Assembly Biosciences
ASMB
$158M
$2.07M ﹤0.01%
44,361
+37,091
+510% +$1.73M
FOXO
3079
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$2.06M ﹤0.01%
+1,058
New +$2.06M
ZYNE
3080
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2.06M ﹤0.01%
388,454
+366,074
+1,636% +$1.94M
ATRS
3081
DELISTED
Antares Pharma, Inc.
ATRS
$2.06M ﹤0.01%
471,254
+1,778
+0.4% +$7.75K
COST icon
3082
Costco
COST
$427B
$2.05M ﹤0.01%
5,183
-232,219
-98% -$91.9M
CENHU
3083
DELISTED
Centricus Acquisition Corp. Unit
CENHU
$2.05M ﹤0.01%
200,000
-1,050,000
-84% -$10.8M
CWEN icon
3084
Clearway Energy Class C
CWEN
$3.29B
$2.05M ﹤0.01%
77,223
+43,848
+131% +$1.16M
CHGG icon
3085
Chegg
CHGG
$162M
$2.04M ﹤0.01%
24,543
-124,358
-84% -$10.3M
FONR icon
3086
Fonar
FONR
$97.4M
$2.04M ﹤0.01%
115,390
+101,837
+751% +$1.8M
WSR
3087
Whitestone REIT
WSR
$652M
$2.04M ﹤0.01%
+247,253
New +$2.04M
SVOK
3088
DELISTED
Seven Oaks Acquisition Corp. Class A Common Stock
SVOK
$2.04M ﹤0.01%
+206,068
New +$2.04M
CLBR.U
3089
DELISTED
Colombier Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-third of one redeemable warrant
CLBR.U
$2.04M ﹤0.01%
+205,278
New +$2.04M
KALU icon
3090
Kaiser Aluminum
KALU
$1.25B
$2.04M ﹤0.01%
16,481
+5,101
+45% +$630K
CLAR icon
3091
Clarus
CLAR
$147M
$2.03M ﹤0.01%
79,155
-149,811
-65% -$3.85M
AGAC
3092
DELISTED
African Gold Acquisition Corporation
AGAC
$2.03M ﹤0.01%
+210,813
New +$2.03M
AWH
3093
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$2.03M ﹤0.01%
24,107
+19,075
+379% +$1.61M
CWBC
3094
Community West Bancshares
CWBC
$402M
$2.03M ﹤0.01%
100,797
+88,868
+745% +$1.79M
KSICU
3095
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$2.03M ﹤0.01%
203,169
-215,581
-51% -$2.15M
ECH icon
3096
iShares MSCI Chile ETF
ECH
$716M
$2.02M ﹤0.01%
69,831
+45,942
+192% +$1.33M
TRIL
3097
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.02M ﹤0.01%
208,072
-572,686
-73% -$5.55M
SYK icon
3098
Stryker
SYK
$144B
$2.02M ﹤0.01%
7,763
-18,506
-70% -$4.81M
MARK
3099
DELISTED
Remark Holdings, Inc.
MARK
$2.01M ﹤0.01%
108,211
-70,823
-40% -$1.32M
SRE icon
3100
Sempra
SRE
$54B
$2.01M ﹤0.01%
30,380
-358,806
-92% -$23.8M